Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Clinical activity of policosanol reported

Oct. 16, 1997

Niaspan clinical activity reported at atherosclerosis symposium

Oct. 16, 1997

Lipogelosomes: a novel approach to lowering cholesterol

Oct. 16, 1997

Preclinical cholesterol-lowering efficacy described for FR-194738

Oct. 16, 1997

Fujisawa's benzimidazole derivatives have broad therapeutic potential

Oct. 15, 1997

Nascobal introduced in U.S., licensed to Meda for Nordic countries

Oct. 15, 1997

Sensus reports early clinical results with B2036-PEG

Oct. 15, 1997

Yamanouchi files for approval of hypoglycemic agent

Oct. 15, 1997

Safety and pharmacokinetics of new hyperlipidemia Rx in humans

Oct. 15, 1997

Bristol-Myers Squibb and Karo Bio to codevelop new therapies for metabolic disorders

Oct. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.